ScoreComparison
Why is Kinarus Therapeutics Holding AG ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-16.77%
EBIT Growth (5y)
-210.80%
EBIT to Interest (avg)
-2.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
7.12
Tax Ratio
6.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
12.71%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.30
EV to EBIT
-3.62
EV to EBITDA
-15.00
EV to Capital Employed
1.32
EV to Sales
5.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-36.59%
ROE (Latest)
-31.22%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial TrendNot enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Kinarus Therapeutics Holding AG
Net Sales
Higher at CHF 4.92 MM
than preceding 12 month period ended Dec 2024MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (CHF MM)
Operating Profit
Highest at CHF -0.23 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CHF MM)
Pre-Tax Profit
Highest at CHF -0.7 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CHF MM)
Pre-Tax Profit
At CHF -0.7 MM has Grown at 98.11%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CHF MM)
Net Profit
At CHF -0.48 MM has Grown at 98.66%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CHF MM)
EPS
Highest at CHF -0.1
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CHF)
Inventory Turnover Ratio
Highest at 14.57%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 8.35%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -148% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Kinarus Therapeutics Holding AG
Interest
At CHF 0.04 MM has Grown at 191.67%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CHF MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
